April 2, 2004

NeoSurg Technologies, Inc. Receives European Patent
for Replaceable Tip Technology

Houston, TX April 2, 2004 - NeoSurg Technologies, Inc., a leading developer of minimally invasive access products for laparoscopic surgery, is pleased to announce that it has been granted a European Patent relating to its replaceable tip delivery technology. The patent, EP 1071376B1, titled "Trocar with Removable Replaceable Tip" covers the replaceable tip for its trocar system, the T2000 Reusable Trocar System. This patent covers the connection feature of the tip.

"We continue to see increased interest in our technology due to ongoing cost constraints and the need for high quality clinical products,” said Pete O’Heeron, President / CEO of NeoSurg Technologies, Inc. This patent broadens our intellectual property and allows us to protect this technology in the European Community.”

NeoSurg owns patents and has numerous pending patent applications for the minimally invasive access market—showing a strong patent position and commitment to developing clinically sophisticated and cost effective solutions. The objective of the patents is to broaden the intellectual property protection worldwide for the T2000 Technology.”

Currently, NeoSurg Technology is protected by over 14 patents and patent applications worldwide.

About the T2000 System
The T2000 System consists of a Reusable Trocar constructed of titanium and hard anodized aluminum for durability and reliability. The access tip is disposable which provides the surgeon with a consistently sharp and controlled penetration. A locking shielding mechanism is attached to the main trocar to guard the tip during insertion.

About NeoSurg Technologies
NeoSurg Technologies, Inc., based in Houston, Texas, is a privately held medical device company focused on bringing breakthrough products for minimally invasive surgery to market. These products are based on the Company’s patented technology, which allows the combination of disposable components with reusable components in a sophisticated and reliable system.

For more information on NeoSurg Technologies, Inc. visit the company Website at www.neosurg.com or contact:

Pete O’Heeron
President and Chief Executive Officer
(281) 461-6211
poheeron@neosurg.com

Certain statements made by the Company which are not historical facts may be considered forward-looking statements, including, and without limitation, statements as to trends, management’s beliefs, expectations and opinions, which are based upon a number of assumptions concerning future conditions that ultimately may prove to be inaccurate. Such forward-looking statements are subject to risks and uncertainties and may be affected by various factors, which may cause actual results to differ materially from those forward-looking statements.

.